Insiders Trades

★ Sign in to follow

ML

Marc Lustig

Aequus Pharmaceuticals Inc.

Cumul. flow

Total declarations

17

Company

1

▲ Purchases (14 ops.)

€34k

▼ Sales (0 ops.)

—

Latest filing published 21 Oct 2025 for Aequus Pharmaceuticals Inc., €5,016.

Filing timeline

BuySale

Marc Lustig

Insider track record

Disclosed buys

14

Disclosed sells

0

Signal history

Marc Lustig: trading record in brief

Marc Lustig is a declared insider of Aequus Pharmaceuticals Inc., with filings sourced from SEDI. Between 15 February 2021 and 25 April 2024, the trades on record add up to 17 filings.

No open-market sale appears; the market trades are 14 purchases worth €34k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. So far in 2025, the count stands at 8 purchases and no sales.

In size, the median ticket on the buying side is €1,646. None of the 14 purchases we analysed coincided with buying by another insider of the same company within 30 days.

Most recently, on 21 October 2025, the filings show an open-market purchase worth €1,101 in Aequus Pharmaceuticals Inc. These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.

Companies and markets linked to Marc Lustig

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Aequus Pharmaceuticals Inc. (CA)

Declarations17 total

▲

4 - Director of IssuerExecutives25 Apr 2024Aequus Pharmaceuticals Inc.

7,350 CAD0SEDI

490,000 shares@ CA$0.01515.0% of flowCommon SharesTSXSEDI:4594706

Canonical exit: 24 Jul 2024 (T+90)

▲

4 - Director of IssuerExecutives4 Mar 2024Aequus Pharmaceuticals Inc.

7,820 CAD0SEDI

391,000 shares@ CA$0.0215.9% of flowCommon SharesTSXSEDI:4594704

Canonical exit: 2 Jun 2024 (T+90)

▲

4 - Director of IssuerExecutives1 Mar 2024Aequus Pharmaceuticals Inc.

15 CAD0SEDI

1,000 shares@ CA$0.0150.0% of flowCommon SharesTSXSEDI:4594702

Canonical exit: 30 May 2024 (T+90)

▲

4 - Director of IssuerExecutives29 Feb 2024Aequus Pharmaceuticals Inc.

1,620 CAD0SEDI

108,000 shares@ CA$0.0153.3% of flowCommon SharesTSXSEDI:4594700

Canonical exit: 29 May 2024 (T+90)

▲

4 - Director of IssuerExecutives21 Nov 2022Aequus Pharmaceuticals Inc.

2,640 CAD0SEDI

88,000 shares@ CA$0.035.7% of flowCommon SharesTSXSEDI:4594696

Canonical exit: 19 Feb 2023 (T+90)

▲

4 - Director of IssuerExecutives18 Nov 2022Aequus Pharmaceuticals Inc.

360 CAD0SEDI

12,000 shares@ CA$0.030.8% of flowCommon SharesTSXSEDI:4594695

Canonical exit: 16 Feb 2023 (T+90)

▲

4 - Director of IssuerExecutives30 Oct 2023Aequus Pharmaceuticals Inc.

3,250 CAD0SEDI

100,000 shares@ CA$0.03256.6% of flowCommon SharesTSXSEDI:4594699

Canonical exit: 28 Jan 2024 (T+90)

▲

4 - Director of IssuerExecutives16 Dec 2022Aequus Pharmaceuticals Inc.

6,625 CAD0SEDI

265,000 shares@ CA$0.02513.6% of flowCommon SharesTSXSEDI:4594698

Canonical exit: 16 Mar 2023 (T+90)

●

4 - Director of IssuerExecutives15 Feb 2021Aequus Pharmaceuticals Inc.

0SEDI

Common SharesTSXSEDI:4594697

●

4 - Director of IssuerExecutives26 Feb 2021Aequus Pharmaceuticals Inc.

1,000,000 CAD0SEDI

6,666,666 shares@ CA$0.15Common SharesTSXSEDI:3994251

▲

4 - Director of IssuerExecutives20 Jul 2022Aequus Pharmaceuticals Inc.

8,400 CAD16SEDI

120,000 shares@ CA$0.0748.8% of flowCommon SharesTSXSEDI:3994081

Canonical exit: 18 Oct 2022 (T+90)

▲

4 - Director of IssuerExecutives22 Jul 2022Aequus Pharmaceuticals Inc.

1,820 CAD16SEDI

26,000 shares@ CA$0.0710.5% of flowCommon SharesTSXSEDI:3994083

Canonical exit: 20 Oct 2022 (T+90)

▲

4 - Director of IssuerExecutives25 Jul 2022Aequus Pharmaceuticals Inc.

4,480 CAD20SEDI

64,000 shares@ CA$0.0726.0% of flowCommon SharesTSXSEDI:3994084

Canonical exit: 23 Oct 2022 (T+90)

▲

4 - Director of IssuerExecutives21 Jul 2022Aequus Pharmaceuticals Inc.

280 CAD13SEDI

4,000 shares@ CA$0.071.6% of flowCommon SharesTSXSEDI:3994082

Canonical exit: 19 Oct 2022 (T+90)

▲

4 - Director of IssuerExecutives25 Jul 2022Aequus Pharmaceuticals Inc.

960 CAD18SEDI

16,000 shares@ CA$0.065.6% of flowCommon SharesTSXSEDI:3994085

Canonical exit: 23 Oct 2022 (T+90)

▲

4 - Director of IssuerExecutives25 Jul 2022Aequus Pharmaceuticals Inc.

1,300 CAD18SEDI

20,000 shares@ CA$0.0657.5% of flowCommon SharesTSXSEDI:3994086

Canonical exit: 23 Oct 2022 (T+90)

●

4 - Director of IssuerExecutives15 Feb 2021Aequus Pharmaceuticals Inc.

0SEDI

Common SharesTSXSEDI:3994080

17 of 17 declarations